Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement

30.09.2022 - - Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases, led by industry veteran and current AavantiBio CEO, Bo Cumbo - - Strong synergies expected by combining key assets, including ...

Related Keywords

United States , Cambridge , Cambridgeshire , United Kingdom , Charlestown , Cornwall , Jessie Hanrahan , Barry Byrne , Scott Lessne , Jenny Marlowe , Stephen Dipalma , Adam Koppel , Caitlin Lowie , Bo Cumbo , Paul Herzich , Roxana Donisa Dreghici , Emanuela Corti , Ilan Ganot , Wilmer Cutler Pickering Hale , Carl Morris , Sidley Austin , Bain Capital Life Sciences , Care Center , Perceptive Advisors , Aavantibio Inc , Companies To Host Conference Call , Nasdaq , Company Pipeline , Exchange Commission , Head Of Clinical Development , University Of Florida Powell Gene Therapy Center , Solid Biosciences Inc , Uf Health , Host Conference Call , Solid Biosciences , Chief Executive , Capital Life Sciences , Caas Capital Management , Laurion Capital Management , Pura Vida , Chief Executive Officer , Dilated Cardiomyopathy , Undisclosed Cardiac , Proposed Transactions , Interim Chief Financial Officer , Chief Scientific Officer , Neuromuscular Diseases , Cardiac Pipeline , Clinical Development , Chief Regulatory Officer , Chief Technology Officer , Chief Administrative , Securities Act , Cutler Pickering Hale , Investor Relations , Powell Gene Therapy Center , Private Securities Litigation Reform Act , Nasdaq Stock Market , Nasdaq Global Select Market , Additional Information Will Be Filed , Media Contact , Bio Media Contact ,